It was reported the patient had an initial procedure on (b)(6) 2014 with a bifurcated stent and an infrarenal aortic extension.On (b)(6) 2016 a follow up and computed tomography (ct) showed a decrease in overlap between the main body and the proximal extension, lateral displacement of stent by about 5mm, the graft material stretched to diameter that appears to be about 4cm, and potential aneurysm sac growth.There was no endoleak observed.Patient has not been scheduled for a secondary procedure.Patient is in stable condition.
|
At the completion of the complaint investigation, based on the information received, the following reported events were confirmed; progressive loss of overlap, stretched fabric of the main body and sac growth.The reported event also indicated there was no presence of an endoleak, however, the clinical evaluation was able to confirm a type 3a endoleak.Additionally there was evidence to reasonably support the following observations; chest pain, shortness of breath, and coronary stent placement four weeks post implant.The clinical evaluation additionally found evidence to reasonably suggest the following contributing factors to the reported event; use of antiplatelet therapy, anticoagulation therapy, preexisting coronary artery disease, factor v leiden deficiency, and recent endovascular repair of an aortic aneurysm.The manufacturing evaluation did not reveal any issues or deviations that would explain the reported event.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The devices remain implanted in the patient and were not available for further evaluation.The root cause of the reported event is unknown.There is not enough information to determine the root cause of the reported event at this time.
|